Innate Pharma (IPHA) EPS (Weighted Average and Diluted) (2020 - 2025)
Innate Pharma (IPHA) reported EPS (Weighted Average and Diluted) of -$85376.0 for Q2 2025, down 6.88% on a YoY basis from -$91679.1 in Q2 2024, and down 6.88% quarter-over-quarter from -$79883.9 in Q2 2024.
Innate Pharma (IPHA) EPS (Weighted Average and Diluted) (2020 - 2025) Analysis & Trends
Innate Pharma has reported EPS (Weighted Average and Diluted) for 6 years, with the latest figure at -$85376.0 in Q2 2025.
- For the quarter ending Q2 2025, EPS (Weighted Average and Diluted) fell 6.88% year-over-year to -$85376.0; the trailing twelve-month figure through Jun 2025 stood at -$85376.0 (down 6.88% YoY), and the FY2025 full-year result was -$0.64, up 1.78% from the prior year.
- EPS (Weighted Average and Diluted) for Q2 2025 stood at -$85376.0, down from -$79883.9 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $182550.0 in Q2 2023, with the low at -$85376.0 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged $3275.5 across 5 years, with a median of -$912.5 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) tumbled 1153654.7% — and 2023, when it jumped 20105.48%.
- Innate Pharma's EPS (Weighted Average and Diluted) stood at $0.08 in 2021, then plunged by 1153654.7% to -$912.5 in 2022, then jumped by 20105.48% to $182550.0 in 2023, then slumped by 143.76% to -$79883.9 in 2024, then fell by 6.88% to -$85376.0 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$85376.0 (Q2 2025), -$79883.9 (Q2 2024), and $182550.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -85,376.00 |
| Jun 30, 2024 | -79,883.87 |
| Jun 30, 2023 | 182,550.00 |
| Jun 30, 2022 | -912.50 |
| Jun 30, 2021 | 0.08 |
| Jun 30, 2020 | -79,492.31 |